Outlook Therapeutics, Inc.
NASDAQ:OTLK · NASDAQ Capital Market
+$0.12 today
Vol 15.72M · Avg 15.13M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-1.78%
Period High
$2.97
Period Low
$0.20
Latest
$1.66
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Century Therapeutics, Inc.
NASDAQ:IPSC
$194.78M
Equillium, Inc.
NASDAQ:EQ
$99.82M
OS Therapies Incorporated
AMEX:OSTX
$75.71M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$71.19M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$66.38M
Cue Biopharma, Inc.
NASDAQ:CUE
$64.46M
Coeptis Therapeutics, Inc.
COEP
$57.63M
Werewolf Therapeutics, Inc.
HOWL
$18.52M
Medicus Pharma Ltd. Common Stock
MDCX
$7.44M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest OTLK filing?
The latest filing shown is 4 dated Jun 3, 2026.
How many recent filings does OTLK have?
Intrinsic Alpha currently shows 20 recent filings for OTLK.
Explore More
Continue the stock analysis
Jump to another research area for this company.